ΠΠ»Π°Π²Π½Π°Ρ ΡΡΡΠ°Π½ΠΈΡΠ°540222 β’ BOM
add
Laurus Labs Ltd
ΠΡΡΡ Π·Π°ΠΊΡΡΡΠΈΡ
586,00Β βΉ
ΠΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ Π·Π° Π΄Π΅Π½Ρ
574,30Β βΉ - 583,50Β βΉ
ΠΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ Π·Π° Π³ΠΎΠ΄
386,85Β βΉ - 660,90Β βΉ
Π ΡΠ½ΠΎΡΠ½Π°Ρ ΠΊΠ°ΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ
310,07Β ΠΌΠ»ΡΠ΄ INR
Π‘ΡΠ΅Π΄Π½ΠΈΠΉ ΠΎΠ±ΡΠ΅ΠΌ ΡΠΎΡΠ³ΠΎΠ²
90,34Β ΡΡΡ.
Π¦Π΅Π½Π°/ΠΏΡΠΈΠ±ΡΠ»Ρ
86,49
ΠΠΈΠ²ΠΈΠ΄Π΅Π½Π΄Π½Π°Ρ Π΄ΠΎΡ
ΠΎΠ΄Π½ΠΎΡΡΡ
0,21Β %
ΠΡΠ½ΠΎΠ²Π½Π°Ρ ΡΠΎΡΠ³ΠΎΠ²Π°Ρ ΠΏΠ»ΠΎΡΠ°Π΄ΠΊΠ°
NSE
ΠΠΎΠ²ΠΎΡΡΠΈ
Π€ΠΈΠ½Π°Π½ΡΠΎΠ²ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ
ΠΡΡΠ΅Ρ ΠΎ ΡΠΈΠ½Π°Π½ΡΠΎΠ²ΡΡ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°Ρ
ΠΠΎΡ
ΠΎΠ΄
Π§ΠΈΡΡΠ°Ρ ΠΏΡΠΈΠ±ΡΠ»Ρ
(INR) | ΠΌΠ°ΡΡ 2025β―Π³.info | ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π³ΠΎΠ΄ |
---|---|---|
ΠΠΎΡ
ΠΎΠ΄ | 17,20Β ΠΌΠ»ΡΠ΄ | 19,49Β % |
ΠΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ Π·Π°ΡΡΠ°ΡΡ | 6,27Β ΠΌΠ»ΡΠ΄ | 31,56Β % |
Π§ΠΈΡΡΠ°Ρ ΠΏΡΠΈΠ±ΡΠ»Ρ | 2,34Β ΠΌΠ»ΡΠ΄ | 209,05Β % |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΠΎ ΡΠΈΡΡΠΎΠΉ ΠΏΡΠΈΠ±ΡΠ»ΠΈ | 13,58 | 158,67Β % |
ΠΡΠΈΠ±ΡΠ»Ρ Π½Π° Π°ΠΊΡΠΈΡ | 4,33 | 209,29Β % |
EBITDA | 4,18Β ΠΌΠ»ΡΠ΄ | 85,34Β % |
ΠΡΡΠ΅ΠΊΡΠΈΠ²Π½Π°Ρ Π½Π°Π»ΠΎΠ³ΠΎΠ²Π°Ρ ΡΡΠ°Π²ΠΊΠ° | 25,21Β % | β |
ΠΡΡ
Π³Π°Π»ΡΠ΅ΡΡΠΊΠΈΠΉ Π±Π°Π»Π°Π½Ρ
ΠΡΠΎΠ³ΠΎ Π°ΠΊΡΠΈΠ²ΠΎΠ²
ΠΡΠΎΠ³ΠΎ ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΡΡΠ²
(INR) | ΠΌΠ°ΡΡ 2025β―Π³.info | ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π³ΠΎΠ΄ |
---|---|---|
ΠΡΠ°ΡΠΊΠΎΡΡΠΎΡΠ½ΡΠ΅ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΈ | 506,40Β ΠΌΠ»Π½ | -64,25Β % |
ΠΡΠΎΠ³ΠΎ Π°ΠΊΡΠΈΠ²ΠΎΠ² | 85,87Β ΠΌΠ»ΡΠ΄ | 2,38Β % |
ΠΡΠΎΠ³ΠΎ ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΡΡΠ² | 40,23Β ΠΌΠ»ΡΠ΄ | -5,82Β % |
ΠΡΠΎΠ³ΠΎ ΡΠΎΠ±ΡΡΠ². ΠΊΠ°ΠΏΠΈΡΠ°Π»Π° | 45,64Β ΠΌΠ»ΡΠ΄ | β |
ΠΠΊΡΠΈΠΉ Π² ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠΈ | 538,41Β ΠΌΠ»Π½ | β |
Π¦Π΅Π½Π°/Π±Π°Π»Π°Π½ΡΠΎΠ²Π°Ρ ΡΡΠΎΠΈΠΌΠΎΡΡΡ | 6,91 | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΡ Π°ΠΊΡΠΈΠ²ΠΎΠ² | β | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΡ ΠΊΠ°ΠΏΠΈΡΠ°Π»Π° | 11,18Β % | β |
ΠΠΎΡΠΎΠΊ Π΄Π΅Π½Π΅ΠΆΠ½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ²
Π§ΠΈΡΡΠΎΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΎΡΡΠ°ΡΠΊΠ° Π΄Π΅Π½Π΅ΠΆΠ½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ²
(INR) | ΠΌΠ°ΡΡ 2025β―Π³.info | ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π³ΠΎΠ΄ |
---|---|---|
Π§ΠΈΡΡΠ°Ρ ΠΏΡΠΈΠ±ΡΠ»Ρ | 2,34Β ΠΌΠ»ΡΠ΄ | 209,05Β % |
Π‘ΡΠ΅Π΄ΡΡΠ²Π° ΠΎΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ | β | β |
Π‘ΡΠ΅Π΄ΡΡΠ²Π° ΠΎΡ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ | β | β |
Π‘ΡΠ΅Π΄ΡΡΠ²Π° ΠΎΡ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ | β | β |
Π§ΠΈΡΡΠΎΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΎΡΡΠ°ΡΠΊΠ° Π΄Π΅Π½Π΅ΠΆΠ½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ² | β | β |
Π‘Π²ΠΎΠ±ΠΎΠ΄Π½ΡΠΉ Π΄Π΅Π½Π΅ΠΆΠ½ΡΠΉ ΠΏΠΎΡΠΎΠΊ | β | β |
ΠΠ±Π·ΠΎΡ
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
ΠΠ΅Π½Π΅ΡΠ°Π»ΡΠ½ΡΠΉ Π΄ΠΈΡΠ΅ΠΊΡΠΎΡ
ΠΠ°ΡΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ
2005
Π‘Π°ΠΉΡ
Π§ΠΈΡΠ»ΠΎ ΡΠΎΡΡΡΠ΄Π½ΠΈΠΊΠΎΠ²
6Β 007